PROS1 and COVID-19: Participants with previous exposure to patients with COVID‐19 did not show significantly higher antibody responses against S protein (99.0% vs. 97.0%, p = 0.5) or RBD (99.0% vs. 97.0%, p = 0.7) than those who had no contact with patients with COVID‐19 (Table 3).